Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains.

Autor: Sekirnik AR; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., Reynolds JK; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., See L; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., Bluck JP; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.; Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K., Scorah AR; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., Tallant C; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 3TA, U.K., Lee B; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., Leszczynska KB; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K., Grimley RL; Worldwide Medicinal Chemistry, Discovery Biology, Pfizer Ltd, The Portway, Granta Park, Cambridge CB21 6GS, U.K., Storer RI; Worldwide Medicinal Chemistry, Discovery Biology, Pfizer Ltd, The Portway, Granta Park, Cambridge CB21 6GS, U.K., Malattia M; Evotec (UK) Ltd, 90 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, U.K., Crespillo S; Evotec (UK) Ltd, 90 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, U.K., Caria S; Evotec (UK) Ltd, 90 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, U.K., Duclos S; Evotec (UK) Ltd, 90 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, U.K., Hammond EM; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K., Knapp S; Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany.; Structural Genomics Consortium, Buchmann Institute for Life Sciences (BMLS), Goethe University, Max-von-Laue-Strasse 15, D-60438 Frankfurt am Main, Germany., Morris GM; Department of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, U.K., Duarte F; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K., Biggin PC; Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K., Conway SJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2022 Oct 21; Vol. 17 (10), pp. 2753-2768. Date of Electronic Publication: 2022 Sep 13.

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.

Autor: Lammoglia Cobo MF; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Ritter J; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gary R; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Seitz V; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; HS Diagnomics GmbH, Berlin, Germany., Mautner J; Department of Medicine III, LMU-Klinikum, Munich, Germany.; German Centre for Infection Research, Munich, Germany., Aigner M; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Völkl S; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Schaffer S; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Moi S; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Seegebarth A; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Bruns H; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Rösler W; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Amann K; Department of Nephropathology, Institute of Pathology, University of Erlangen, Erlangen, Germany., Büttner-Herold M; Department of Nephropathology, Institute of Pathology, University of Erlangen, Erlangen, Germany., Hennig S; HS Diagnomics GmbH, Berlin, Germany., Mackensen A; Department of Internal Medicine 5 -Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Hummel M; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Moosmann A; Department of Medicine III, LMU-Klinikum, Munich, Germany.; German Centre for Infection Research, Munich, Germany., Gerbitz A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.

Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Apr 22; Vol. 18 (4), pp. e1010206. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).

Study on the cellular internalization mechanisms and in vivo anti-bone metastasis prostate cancer efficiency of the peptide T7-modified polypeptide nanoparticles.

Autor: Gu Y; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; School of Pharmacy, Second Military Medical University, Shanghai, China., Chen X; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China., Zhang H; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China., Wang H; Department of Pharmacy, Inner Mongolia Medical University, Huhhot, China., Chen H; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China., Huang S; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China., Xu Y; Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, China., Zhang Y; Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, China., Wu X; School of Pharmacy, Second Military Medical University, Shanghai, China.; Shanghai Wei Er Biopharmaceutical Technology Co., Ltd, Shanghai, China., Chen J; Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; Department of Pharmacy, Inner Mongolia Medical University, Huhhot, China.

Publikováno v: Drug delivery [Drug Deliv] 2020 Dec; Vol. 27 (1), pp. 161-169.

Peptide T exhibits a well-defined structure in fluorinated solvent at low temperature.

Autor: Yang TC; Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, Canada., Rendell J, Gulliver W, Booth V

Publikováno v: Journal of peptide science : an official publication of the European Peptide Society [J Pept Sci] 2009 Dec; Vol. 15 (12), pp. 818-23.

Peptide T-araC conjugates: solid-phase synthesis and biological activity of N4-(acylpeptidyl)-araC.

Autor: Manfredini S; Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Italy., Marastoni-M, Tomatis R, Durini E, Spisani S, Pani A, Marceddu T, Musiu C, Marongiu ME, La Colla P

Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2000 Mar; Vol. 8 (3), pp. 539-47.